Their main rival, sibutramine (Reductil), claims similar benefits in clinical trials but, once again, real-world results tend to be disappointing.

• 他们的主要竞争对手，西布曲明（诺美亭），声称在试点诊所也有相似的疗效，但是事实却再一次让人们失望。